Pre-open movers
U.S. stock futures traded higher in early pre-market trade., ahead of earnings from JPMorgan Chase & Co. (NYSE:
JPM), Wells Fargo & Company (NYSE: WFC) and The PNC Financial Services Group, Inc. (NYSE:
PNC). Federal Reserve Chairman Jerome Powell is set to speak
in Leesburg, Virginia. Data on import and export prices for March will be released at 8:30 a.m. ET, while the University of
Michigan's consumer sentiment index for April is schedule for release at 10:00 a.m. ET.
Futures for the Dow Jones Industrial Average rose 168 points to 26,301.00, while the Standard & Poor’s 500 index futures gained
13.25 points to 2,905.00. Futures for the Nasdaq 100 index climbed 33.25 points to 7,651.25.
Oil prices traded higher as Brent crude futures rose
1 percent to trade at $71.53 per barrel, while US WTI crude futures climbed 1.4 percent to trade at $64.47 a barrel. The Baker
Hughes North American rig count report for the recent week will be released at 1:00 p.m. ET.
A Peek Into Global Markets
European markets were higher today, with the Spanish Ibex Index rising 0.2 percent, STOXX Europe 600 Index gaining 0.1 percent
and German DAX 30 index gained 0.5 percent. The UK's FTSE index was trading higher by 0.4 percent, while French CAC 40 Index rose
0.3 percent.
In Asian markets, Japan’s Nikkei Stock Average rose 0.73 percent, Hong Kong’s Hang Seng Index climbed 0.24 percent, China’s
Shanghai Composite Index fell 0.04 percent and India’s BSE Sensex rose 0.41 percent.
Broker Recommendation
Analysts at KeyBanc downgraded W. R. Grace & Co. (NYSE: GRA) from Overweight to Sector Weight.
W R Grace shares fell 0.28 percent to close at $77.31 on Thursday.
Breaking News
-
Chevron Corporation (NYSE: CVX) announced
plans to acquire Anadarko Petroleum Corporation (NYSE: APC) for $33 billion.
-
Ophthotech Corp (NASDAQ: OPHT) shares
climbed over 10 percent in pre-market trading after the company obtained an exclusive global license to the AAV gene therapy
program.
-
AZZ Inc (NYSE: AZZ) reported the purchase
of K2 Partners.
-
Viveve Medical Inc (NASDAQ: VIVE)
shares surged around 35 percent in pre-market trading following news of CE Mark clearance for its next-gen 2.0 platform in the
European Union.
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.